Hormone therapy challenged

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version

January 24, 2009

By BARBARA MINTZES

If a model of airplane crashed more often than expected, what would happen if the manufacturer funded new guidelines saying the data on crashes had been reanalyzed, and short trips are perfectly safe (HRT Safe To Treat Menopause, MDs Say - Life, Jan. 23)? Would The Globe report "Airplane Safe For Short Trips, New Guidelines Say" without going into detail on the source of the funding for the guidelines?

The six authors of the Society of Obstetricians and Gynaecologists of Canada guidelines declare 59 conflicts of interest involving drug companies, mainly as speakers, consultants and advisory board members. Would the guidelines have been so critical of evidence of harm of hormone replacement therapy (HRT) had they been independent?

Read the full story in the Globe and Mail.





Read a related story by Sharon Kirkey.